In continuation of the company's announcement dated 2 November 2011 concerning a planned share repurchase programme, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2011 owned 24,440,186 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 24,440,186 or 4.21% of the total share capital.
Media: |
Investors: |
Anne Margrethe Hauge |
Klaus Bülow Davidsen |
Tel: (+45) 4442 3450 |
Tel: (+45) 4442 3176 |
Frank Daniel Mersebach | |
Tel: (+45) 4442 0604 | |
Lars Borup Jacobsen | |
Tel: (+45) 3075 3479 | |
In North America: | |
Ken Inchausti |
Jannick Lindegaard |
Tel: (+1) 609 514 8316 |
Tel: (+1) 609 786 4575 |
Company Announcement no 1 / 2012